Nourocognitive late effects in pediatric cancer

Current Problems in Cancer

Volumn 27, Issue 4, 2003, Pages 177-197

  Mulhern, Raymond K ^a   Palmer, Shawna L ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; DEXAMETHASONE; METHOTREXATE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ACADEMIC ACHIEVEMENT; ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ATTENTION; BRAIN FUNCTION; BRAIN SIZE; BRAIN TUMOR; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURGERY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DAILY LIFE ACTIVITY; DEMYELINATION; DISEASE ASSOCIATION; DRUG EFFECT; ETHNOLOGY; GENDER; GLIOMA; GROWTH RETARDATION; HEARING LOSS; HORMONE DEFICIENCY; HUMAN; HYDROCEPHALUS; IMAGE ANALYSIS; INCIDENCE; INTELLIGENCE; INTELLIGENCE TEST; LEARNING DISORDER; LEUKOENCEPHALOPATHY; MEDULLOBLASTOMA; MEMORY; NEUROBIOLOGY; NEUROPATHOLOGY; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PROGNOSIS; PSYCHOSOCIAL ENVIRONMENT; QUALITY OF LIFE; RADIATION DOSE; REVIEW; RISK FACTOR; SECOND CANCER; SEIZURE; SOCIAL STATUS; THINKING; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; CHILD; FEMALE; MALE; RADIOTHERAPY;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD; COGNITION DISORDERS; FEMALE; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; RADIOTHERAPY;

EID: 0038036359     PISSN: 01470272     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-0272(03)00026-6     Document Type: Article

References (73)

1. Ries LAG, Smith MA, Gurney JG, et al. Cancer incidence and survival among children and adolescents: United States, SEER Program, 1975-1995. National Institutes of Health Publication No. 99-4649. Bethesda, MD: National Institutes of Health, 1999.
2. Roman DH, Sperduto PW. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 1995;31:983-98.
3. Ris MD, Noll RB. Long-term neurobehavioral outcome in pediatric brain-tumor patients: review and methodological critique. J Clin Exp Neuropsychol 1994;16: 21-42.
4. Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 2000;15:603-30.
5. Maden-Swain A, Brown RT. Cognitive and psychosocial sequelae for children with acute lymphocytic leukemia and their families. Clin Psychol Rev 1991;11:267-94.
6. Butler RW, Copeland DR. Neuropsychological effects of central nervous system prophylactic treatment in childhood leukemia: methodological considerations. J Pediatr Psychol 1993;18:319-38.
7. Steen G, Mirro J. Childhood cancer: a handbook from St. Cambridge, MA: Perseus Publishing Jude Children's Research Hospital, 2000.
8. Rubenstein CL, Varni JW, Katz ER. Cognitive functioning in long-term survivors of childhood leukemia: a prospective analysis. Dev Behav Pediatr 1990;11:301-5.
9. Mulhern RK, Fairclough D, Ochs J. A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation. J Clin Oncol 1991;9:1348-56.
10. Espy KA, Moore IM, Kaufmann PM, et al. Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study. J Pediatr Psychol 2001;26:1-9.
11. Brown RT, Madan-Swain A, Walco GA, et al. Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. J Pediatr Psychol 1998;23:333-40.
12. Copeland DR, Moore BD, Francis DJ, et al. Neuropsychologic effects of chemotherapy on children with cancer: a longitudinal study. J Clin Oncol 1996;14:2826-35.
13. Waber DP, Carpentieri SC, Klar N, et al. Cognitive sequelae in children treated for acute lymphoblatic leukemia with dexamethasone or prednisone. J Pediatr Hematol Oncol 2000;22:206-13.
14. Heideman RL, Packer RJ, Albright LA, et al. Tumors of the central nervous system. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 2nd edition, Philadephia: J.B. Lippincott, 1997:633-81.
15. Glauser TA, Packer RJ. Cognitive deficits in long-term survivors of childhood brain tumors. Childs Nerv Syst 1991;7:7-12.
16. Dennis M, Spiegler B, Hetherington CR, Greenberg M. Neuropsychological sequelae of the treatment of children with medulloblastoma. J Neurooncol 1996; 29:91-101.
17. Mulhern RK, Reddick WE, Palmer SL, et al. Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol 1999;46:834-41.
18. Palmer SL, Goloubeva O, Reddick WE, et al. Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. J Clin Oncol 2001;19:2302-8.
19. Mulhern RK, Kepner JL, Thomas PRM, et al. Neuropsychological functioning of survivors of childhood medulloblastoma randomized to receive conventional (3,600 cGy/20) or reduced (2,340 cGy/13) dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol 1998;16:1723-8.
20. Silber JH, Radcliffe J, Peckham V, et al. Whole-brain irradiation and decline in intelligence: the influence of dose and age of IQ score. J Clin Oncol 1992;10: 1390-6.
21. Packer RJ, Meadows AT, Rorke LB, et al. Long-term sequelae of cancer treatment on the central nervous system in childhood. Med Pediatr Oncol 1987;15:241-53.
22. Ellenberg L, McComb JG, Siegel SE, Stowe S. Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurgery 1987;21:638-44.
23. Rankin EJ, Adams RL, Jones HE. Epilepsy and nonepileptic attack disorder. In: Adams RL, Parsons OA, Culbertson JL, Nixon SJ, editors. Neuropsychology for clinical practice: etiology, assessment, and treatment of common neurological disorders. Washington, DC: American Psychological Association, 1996:131-73.
24. Jannoun L, Bloom HJG. Long-term psychological effects in children treated for intracranial tumors. Int J Radiat Oncol Biol Phys 1990;18:747-53.
25. Scott MA, Fletcher JM, Brookshire BL. Memory functions in children with early hydrocephalus. Neuropsychology 1998;12:578-89.
26. Mostow EN, Byrne J, Connelly RR, et al. Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J Clin Oncol 1991;9:592-9.
27. Haupt R, Fears TR, Robison LL, et al. Educational attainment in long-term survivors of acute lymphoblastic leukemia. JAMA 1994;272:1427-32.
28. Zeltzer LK, Chen E, Weiss R, et al. Comparison of psychologic outcome in adult survivors of childhood acute lymphoblastic leukemia versus sibling controls: a Cooperative Children's Cancer Group and National Institutes of Health study. J Clin Oncol 1997;15:547-56.
29. Said JA, Waters BGH, Cousens P, Stevens MM. Neuropsychological sequelae of central nervous system prophylaxis in survivors of childhood acute lymphoblastic leukemia. J Consult Clin Psychol 1989;57:251-6.
30. Mulhern RK, Kovnar E, Langston J, et al. Long-term survivors of leukemia treated in infancy: factors associated with neuropsychologic status. J Clin Oncol 1992;10: 1095-102.
31. Rodgers J, Horrocks J, Britton PG, et al. Attention ability among survivors of leukemia. Arch Dis Child 1999;80:318-23.
32. Lockwood KA, Bell TS, Colegrove RW. Long-term effects of cranial radiation therapy on attention functioning in survivors of childhood leukemia. J Pediatr Psychol 1999;24:55-66.
33. Mulhern RK, Wasserman AL, Fairclough DL, Ochs JO. Memory function of children with acute lymphocytic leukemia who received central nervous system prophylaxis with or without 1800 cGy cranial irradiation. J Clin Oncol 1988;6: 315-20.
34. Brown RT, Madan-Swain A, Pais R, et al. Chemotherapy for acute lymphocytic leukemia: cognitive and academic sequelae. J Pediatr 1992;121:885-9.
35. Cousens P, Ungerer JA, Crawford JA, Stephens MM. Cognitive effects of childhood leukemia therapy: a case for four specific deficits. J Pediatr Psychol 1991;16:475-88.
36. Dennis M, Hetherington CR, Spiegler B. Memory and attention after childhood brain tumors. Med Pediatr Oncol Suppl 1998;1:25-33.
37. Schatz J, Kramer JH, Albin A, Matthay KK. Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology 2000;14:89-200.
38. Constine LS, Konski A, Ekholm S, et al. Adverse effects of brain irradiation correlated with MR and CT imaging. Int J Radiat Oncol Biol Phys 1988;15:319-30.
39. Tsuruda JS, Kortman KE, Bradley WG, et al. Radiation effects on cerebral white matter MR evaluation. Am J Neuroradiol 1987;8:431-7.
40. Schultheiss TE, Kun LE, Ang KK, Stephens LC. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 1995;31:1093-112.
41. Barkovich AJ. Concepts of myelin and myelination in neuroradiology. Am J Neuroradiol 2000;21:1099-109.
42. Sowell ER, Thompson PM, Holmes CJ, et al. In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat Neurosci 1999;2:859-61.
43. Fern R, Moller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci 2000;20:34-42.
44. Reddick WE, Glass JO, Cook EN, et al. Automated segmentation and classification of multispectral magnetic resonance images of brain using artificial neural networks. IEEE Transact Med Imaging 1997;16:911-8.
45. Burger PC, Boyko OB. The pathology of central nervous system radiation injury. In: Gutin PH, Leibel SA, Sheline GE, editors. Radiation injury to the nervous system. New York: Raven Press, 1991:3-15.
46. Reddick WE, Mulhern RK, Elkin TD, et al. A hybrid neural network analysis of subtle brain volume differences in children surviving brain tumors. Magn Reson Imaging 1998;16:413-21.
47. Reddick WE, Russell JM, Glass JO, et al. Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magn Reson Imaging 2000;18:787-93.
48. Hudson M. Late complications after leukemia therapy. In: Pui CH, editor. Childhood leukemias. Cambridge, MA: Cambridge University Press, 1999:463-81.
49. Lee YY, Nauert C, Glass P. Treatment-related white matter changes in cancer patients. Cancer 1986;57:1473-82.
50. Reddick WE, Glass JO, Langston JW, Helton KJ. Quantitative MRI assessment of leukoencephalopathy. Magn Reson Med 2002;47:912-20.
51. Filley CM. The behavioral neurology of cerebral white matter. Neurology 1998; 50:1535-40.
52. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive functions: the Rotterdam scan study. Ann Neurol 2000;47:145-51.
53. Mulhern RK, Palmer SL, Reddick WE, et al. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol 2001;19:472-9.
54. Waber DP, Urion DK, Tarbell NJ, et al. Late effects of central nervous system treatment of acute lymphoblastic leukemia in childhood are sex-dependent. Dev Med Child Neurol 1990;32:238-48.
55. Waber DP, Tarbell NJ, Kahn CM, et al. The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia. J Clin Oncol 1992;10:810-7.
56. Waber DP, Tarbell NJ, Fairclough D, et al. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol 1995;13:2490-6.
57. Pfefferbaum A, Mathalon DH, Sullivan EV, et al. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 1994;51:874-87.
58. Satz P. Brain reserve capacity on symptom onset after brain injury: a reformulation and review of evidence for threshold theory. Neuropsychology 1993;7:273-95.
59. Thiel A, Herholz K, Koyuncu A, et al. Plasticity of language networks in patients with brain tumors: a positron emission tomography activation study. Ann Neurol 2001;50:620-9.
60. Vanderploeg RD, Schinka JA, Baum KM. WISC-III premorbid prediction strategies: demographic and best performance approaches. Psychol Assess 1998; 10:277-84.
61. Butler R, Hill JM, Steinherz PG, et al. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol 1994;12:2621-9.
62. Butler R, Copeland DR. Attentional processes and their remediation in children treated for cancer: A literature review and the development of a therapeutic approach. J Int Neuropsychol Soc 2002;8:115-24.
63. Meyers CA, Weitzner MA, Valentine AD, et al. Methylphenidate therapy improves cognition, mood and function of brain tumor patients. J Clin Oncol 1998;16:2522-7.
64. Thompson SJ, Leigh L, Christensen R, et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of cancer. J Clin Oncol 2001;19: 1802-8.
65. Armstrong FD, Blumberg MJ, Tolendano SR. Neurobehavioral issues in childhood cancer. School Psychol Q 1999;28:194-203.
66. Louis DN, Posner J. Report of the Brain Tumor Progress Review Group. National Institutes of Health Publication No. 01-4902. Bethesda, MD: National Institutes of Health, 2000.
67. Wechsler D. Wechsler individual achievement test. San Antonio, TX: The Psychological Corporation, 1992.
68. Wechsler D. Wechsler intelligence scale for children, third edition. San Antonio, TX: The Psychological Corporation, 1991.
69. Golden CJ. Stroop color and word test. Woodale, IL: Stoelting Company, 1978.
70. Conners CK. Conners' continuous performance test. North Tonawanda, NY: Multihealth Systems, 1995.
71. Conners CK. The Conners rating scales. North Tonawanda, NY: Multihealth Systems, 1990.
72. Cohen MJ. Children's memory scale. San Antonio, TX: The Psychological Corporation, 1997.
73. Adams W, Sheslow D. Wide range assessment of memory and learning (WRAML). Wilmington, DE: Jastak Associates, 1990.